• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Jon Cohen and Michael Hansen Join Talkspace's Board of Directors

    9/15/22 4:05:00 PM ET
    $OPK
    $TALK
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Nursing Services
    Health Care
    Get the next $OPK alert in real time by email

    NEW YORK, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Shareholders of Talkspace, Inc. (NASDAQ:TALK) today elected Jon Cohen, M.D., to the virtual behavioral healthcare company's board of directors and approved all other shareholder proposals during the company's first Annual Meeting of Stockholders.

    Dr. Cohen is prior Executive Chairman and Chief Executive Officer of BioReference Laboratories and Senior Vice President of OPKO Health (NASDAQ:OPK). Dr. Cohen brings 30 years of healthcare industry strategy and operating experience to Talkspace's board of directors. He succeeds Jeffrey Crowe as an independent Class I Director with a term expiring in 2025.

    Additionally, the Company's board appointed Cengage Group Chief Executive Officer Michael Hansen to complete Charles Berg's term as a Class II director expiring in 2023. Mr. Hansen, a digital transformation expert, previously served as partner and Chairman at the Boston Consulting Group's digital convergence practice. He's been named one of Fast Company's Most Creative People in Business and twice been recognized as a top CEO by Glassdoor.

    Finally, Talkspace shareholders approved the following proposals, all of which were supported by the Board:

    • Re-election of Erez Shachar and Madhu Pawar as independent Class I directors with terms expiring in 2025;



    • Ratification of appointment of independent auditors; and



    • Approval of current year's executive compensation and approval of review of executive compensation on an annual basis going forward.

    About Talkspace

    Talkspace (NASDAQ:TALK) is a leading virtual behavioral healthcare company committed to helping people lead healthier, happier lives through access to high-quality mental healthcare. At Talkspace, we believe that mental healthcare is core to overall healthcare and should be available to everyone.

    Talkspace pioneered the ability to text with a licensed therapist from anywhere and now offers a comprehensive suite of mental health services from self-guided products to individual, couples and family therapy, in addition to psychiatric treatment and medication management. With Talkspace's core psychotherapy offering, members are matched with one of thousands of licensed providers across all 50 states and can choose from a variety of subscription plans including video, text or audio chat sessions and/or unlimited text messaging.

    All care offered at Talkspace is delivered through an easy-to-use, fully-encrypted web and mobile platform that meets HIPAA, federal, and state regulatory requirements. Talkspace covered approximately 77 million lives at June 30, 2022, through our partnerships with employers, health plans, and paid benefits programs.

    For more information, visit www.talkspace.com.

    Contacts

    ‍For Investors:

    Mike Lovell, Senior Director Investor Relations

    515-771-1585

    [email protected]

    For Media:

    SKDK

    John Kim

    310-997-5963

    [email protected] 



    Primary Logo

    Get the next $OPK alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $OPK
    $TALK

    CompanyDatePrice TargetRatingAnalyst
    OPKO Health Inc.
    $OPK
    4/25/2025Neutral
    Analyst
    Talkspace Inc.
    $TALK
    4/3/2025$5.00Buy
    Canaccord Genuity
    Talkspace Inc.
    $TALK
    12/9/2024$4.50Overweight
    KeyBanc Capital Markets
    Talkspace Inc.
    $TALK
    12/4/2024$5.00Outperform
    Mizuho
    Talkspace Inc.
    $TALK
    11/20/2024$5.00Outperform
    Northland Capital
    Talkspace Inc.
    $TALK
    7/1/2024Hold
    Needham
    Talkspace Inc.
    $TALK
    1/3/2024$2.50Equal Weight
    Barclays
    OPKO Health Inc.
    $OPK
    6/29/2023$2.00Mkt Perform → Outperform
    Barrington Research
    More analyst ratings

    $OPK
    $TALK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CEO & Chairman Frost Phillip Md Et Al bought $169,712 worth of shares (125,000 units at $1.36) (SEC Form 4)

      4 - OPKO HEALTH, INC. (0000944809) (Issuer)

      4/10/25 5:07:15 PM ET
      $OPK
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • CEO & Chairman Frost Phillip Md Et Al bought $184,650 worth of shares (125,000 units at $1.48) (SEC Form 4)

      4 - OPKO HEALTH, INC. (0000944809) (Issuer)

      4/8/25 5:34:21 PM ET
      $OPK
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • CEO & Chairman Frost Phillip Md Et Al bought $164,850 worth of shares (100,000 units at $1.65) (SEC Form 4)

      4 - OPKO HEALTH, INC. (0000944809) (Issuer)

      4/1/25 5:21:45 PM ET
      $OPK
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $OPK
    $TALK
    SEC Filings

    See more
    • Talkspace Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Talkspace, Inc. (0001803901) (Filer)

      6/23/25 5:15:31 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • OPKO Health Inc. filed SEC Form 8-K: Leadership Update

      8-K - OPKO HEALTH, INC. (0000944809) (Filer)

      5/29/25 5:00:31 PM ET
      $OPK
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by Talkspace Inc.

      SCHEDULE 13G/A - Talkspace, Inc. (0001803901) (Subject)

      5/15/25 5:31:31 PM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $OPK
    $TALK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Analyst initiated coverage on Opko Health

      Analyst initiated coverage of Opko Health with a rating of Neutral

      4/25/25 8:32:28 AM ET
      $OPK
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Canaccord Genuity initiated coverage on Talkspace with a new price target

      Canaccord Genuity initiated coverage of Talkspace with a rating of Buy and set a new price target of $5.00

      4/3/25 8:18:33 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • KeyBanc Capital Markets initiated coverage on Talkspace with a new price target

      KeyBanc Capital Markets initiated coverage of Talkspace with a rating of Overweight and set a new price target of $4.50

      12/9/24 8:34:29 AM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $OPK
    $TALK
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • OPKO Health to Report Second Quarter 2025 Financial Results on July 31

      MIAMI, July 24, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) plans to report operating and financial results for the three and six months ended June 30, 2025 after the close of the U.S. financial markets on Thursday, July 31, 2025. OPKO's senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on July 31 beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encourages participants to pre-register for the conference call using this link. Callers who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. Participa

      7/24/25 4:05:00 PM ET
      $OPK
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Talkspace and Tia Health team to address women's mental health needs at all stages of life

      Talkspace to be Tia's Primary Therapy and Psychiatric Services Partner, Providing Care Continuity and Enhancing Primary Care Offerings Talkspace (NASDAQ:TALK), a leading online behavioral healthcare company, today announced a partnership with Tia Health, a primary care provider for women, to integrate mental health care services into key primary care services for the women Tia serves. The partnership represents Talkspace's continued expansion into specialized women's health services, building on its collaboration with women's health providers to address the unique mental health challenges that women face throughout their lives. The relationship comes amid growing concerns around the m

      7/22/25 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace to Report Second Quarter 2025 Results and Host Conference Call

      NEW YORK, July 21, 2025 (GLOBE NEWSWIRE) -- Talkspace (NASDAQ:TALK), a leading behavioral healthcare company, today announced that it will release its second quarter 2025 results on Tuesday, August 5, 2025, before market open and host a conference call to review the results at 8:30am ET. Conference Call DetailsThe conference call will be available via audio webcast at https://investors.talkspace.com/ and can also be accessed by dialing (888) 596-4144 for U.S. participants, or +1 (646) 968-2525 for international participants, and using conference ID 8668160. A replay will be available shortly after the call's completion and remain available for approximately 90 days. About TalkspaceTalksp

      7/21/25 4:05:00 PM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $OPK
    $TALK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Technology Officer Margolin Gil sold $56,227 worth of shares (19,302 units at $2.91), decreasing direct ownership by 7% to 262,616 units (SEC Form 4)

      4 - Talkspace, Inc. (0001803901) (Issuer)

      6/17/25 9:00:04 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Chief Executive Officer Cohen Jon R covered exercise/tax liability with 83,978 shares, decreasing direct ownership by 3% to 2,489,082 units (SEC Form 4)

      4 - Talkspace, Inc. (0001803901) (Issuer)

      6/12/25 9:00:05 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Chief Technology Officer Margolin Gil covered exercise/tax liability with 12,023 shares, decreasing direct ownership by 4% to 281,918 units (SEC Form 4)

      4 - Talkspace, Inc. (0001803901) (Issuer)

      6/12/25 9:00:08 PM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $OPK
    $TALK
    Leadership Updates

    Live Leadership Updates

    See more
    • OPKO Health's ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development

      WESTON, Mass., Sept. 23, 2024 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health, Inc. (NASDAQ:OPK) company, today announced the appointment of Giovanni Abbadessa, M.D., Ph.D. as Chief Medical Officer, a newly created position. Dr. Abbadessa has over two decades of experience in drug development, including most recently as Vice President at Sanofi, where he provided executive leadership for advancing oncology assets. "Dr. Abbadessa's deep experience in leading early-stage oncology development makes him the ideal fit to steer development of our multispecific antibodies for cancer and other clinical indications," said Dr. Gary Nabel, co-founder, President and CEO of ModeX Thera

      9/23/24 8:00:00 AM ET
      $OPK
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Talkspace Partners With Amazon Health Services to Help Millions Discover Mental Health Benefits

      New collaboration aims to improve awareness of, and expand access to, online therapy and psychiatry services to the 150+ million people who have Talkspace as a covered benefit Talkspace (NASDAQ:TALK), a leading online behavioral health care company, today announced a partnership with Amazon Health Services to increase awareness and discoverability of its mental health care services on Amazon.com. Talkspace is the first virtual behavioral health provider to join Amazon Health Services' program to help individuals discover and enroll in their health insurance benefits at no extra cost or for a small copay. With more than 5,000 therapists and providers across 50 states, Talkspace improves acc

      9/17/24 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace and the Professional Tennis Players Association Join Forces to Support Mental Health of Athletes Year Round

      Today, Talkspace (NASDAQ:TALK), a leading online behavioral health care company, announced its partnership with the Professional Tennis Players Association (PTPA), global advocates for professional tennis players. Talkspace will serve as the PTPA's exclusive mental health technology partner, granting players, their families, and their support teams free, 24/7 access to Talkspace's self-guided therapy app, Talkspace Go, as well as discounted access to its virtual therapy offering. "Talkspace is honored to join forces with the PTPA as its exclusive mental health provider, dedicated to delivering high-quality, evidence-based support where and when players need it. This collaboration undersco

      8/28/24 9:06:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $OPK
    $TALK
    Financials

    Live finance-specific insights

    See more
    • OPKO Health to Report Second Quarter 2025 Financial Results on July 31

      MIAMI, July 24, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) plans to report operating and financial results for the three and six months ended June 30, 2025 after the close of the U.S. financial markets on Thursday, July 31, 2025. OPKO's senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on July 31 beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encourages participants to pre-register for the conference call using this link. Callers who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. Participa

      7/24/25 4:05:00 PM ET
      $OPK
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Talkspace to Report Second Quarter 2025 Results and Host Conference Call

      NEW YORK, July 21, 2025 (GLOBE NEWSWIRE) -- Talkspace (NASDAQ:TALK), a leading behavioral healthcare company, today announced that it will release its second quarter 2025 results on Tuesday, August 5, 2025, before market open and host a conference call to review the results at 8:30am ET. Conference Call DetailsThe conference call will be available via audio webcast at https://investors.talkspace.com/ and can also be accessed by dialing (888) 596-4144 for U.S. participants, or +1 (646) 968-2525 for international participants, and using conference ID 8668160. A replay will be available shortly after the call's completion and remain available for approximately 90 days. About TalkspaceTalksp

      7/21/25 4:05:00 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace Announces First Quarter 2025 Results

      1Q 2025 Total revenue grew 15% year-over-year to $52.2 million driven by 33% year-over-year growth in Payor revenue 1Q 2025 Net income of $0.3 million and adjusted EBITDA1 of $2.0 million 1Q 2025 Share repurchases of $7.0 million NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Talkspace, Inc. ("Talkspace" or the "Company") (NASDAQ:TALK), today reported first quarter 2025 financial results.   Three Months Ended March 31, 2025     Unaudited Results % Variance fromPrior Year (In thousands unless otherwise noted)     Number of completed Payor sessions during the period  350.0  23% Number of Unique Active Payor members during the period  101.2  17%       Total revenue $52,182  15% G

      5/6/25 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $OPK
    $TALK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by OPKO Health Inc.

      SC 13D/A - OPKO HEALTH, INC. (0000944809) (Subject)

      11/15/24 4:39:33 PM ET
      $OPK
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13G filed by OPKO Health Inc.

      SC 13G - OPKO HEALTH, INC. (0000944809) (Subject)

      11/13/24 4:30:24 PM ET
      $OPK
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SC 13G/A filed by OPKO Health Inc.

      SC 13G/A - OPKO HEALTH, INC. (0000944809) (Subject)

      11/12/24 4:54:06 PM ET
      $OPK
      Biotechnology: Pharmaceutical Preparations
      Health Care